[Recombinant human growth hormone effects on growth in cystic fibrosis]
Medical Journal of Tabriz University of Medical Sciences and Health Services. 2017; 39 (4): 71-77
en Persa
| IMEMR
| ID: emr-194990
ABSTRACT
Background:
Growth retardation is a common finding in cystic fibrosis [CF] patients. Recombinant human growth hormone [rhGH] has shown promising results in improving weight, height and clinical status of CF patients. In this study we aim to evaluate efficacy of rhGH on physical growth, clinical status and pulmonary function in CF patients
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Idioma:
Persa
Revista:
Med. J. Tabriz Univ. Med. Sci. Health Serv.
Año:
2017
Similares
MEDLINE
...
LILACS
LIS